Cargando…

Pregabalin in Monitored Anesthesia Care for Ear-nose-throat Surgery

AIM: The aim of this study was to determine intraoperative sedative and perioperative analgesic requirement and associated side effects of pregabalin (150 mg) for monitored anesthesia care during ear-nose-throat (ENT) surgeries. MATERIALS AND METHODS: The study design was randomized and single-blind...

Descripción completa

Detalles Bibliográficos
Autores principales: Kochhar, Anjali, Banday, Jahanara, Ahmad, Zainab, Monga, Seema, Vajifdar, Homay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5490097/
https://www.ncbi.nlm.nih.gov/pubmed/28663620
http://dx.doi.org/10.4103/0259-1162.194589
_version_ 1783246914743959552
author Kochhar, Anjali
Banday, Jahanara
Ahmad, Zainab
Monga, Seema
Vajifdar, Homay
author_facet Kochhar, Anjali
Banday, Jahanara
Ahmad, Zainab
Monga, Seema
Vajifdar, Homay
author_sort Kochhar, Anjali
collection PubMed
description AIM: The aim of this study was to determine intraoperative sedative and perioperative analgesic requirement and associated side effects of pregabalin (150 mg) for monitored anesthesia care during ear-nose-throat (ENT) surgeries. MATERIALS AND METHODS: The study design was randomized and single-blinded; fifty patients undergoing elective ambulatory ENT surgeries under monitored anesthesia care were randomly allocated to receive either placebo (Group P) or pregabalin (Group PG) 150 mg, orally 1 h before surgery. All patients were then given intravenous (i.v.) midazolam 2 mg and fentanyl 1 μg/kg and local anesthesia at the site. Sedation was induced by administering an i.v. bolus of propofol 0.8 mg/kg and was maintained by continuous infusion of propofol. Level of sedation was assessed by Ramsay scale, and propofol infusion was titrated accordingly. Intraoperative pain was assessed by verbal rating scale (VRS) score. Patient having VRS >4 or complaint of pain was given fentanyl (0.5 μg/kg) i.v. bolus. Intraoperative sedative and analgesic requirement were recorded. Postoperative visual analog scale scores and requirement of analgesics were recorded for the first 24 h after surgery. Diclofenac 75 mg intramuscular (i.m.) was administered as rescue analgesic. Side effects (nausea/vomiting, sedation, dizziness, blurred vision) were also recorded. RESULTS: Intraoperative propofol (212 ± 11 mg vs. 174 ± 9 mg; P = 0.013) and fentanyl (120 ± 8 μg vs. 94 ± 6 μg; P = 0.02) consumption was significantly lower in Group PG. Time to first analgesic request was longer (6.1 ± 0.4 h vs. 9.5 ± 1.2 h) with lesser requirement of analgesics (diclofenac) in the postoperative period. Incidence of side effects (sedation, nausea, vomiting) was found to be similar in both the groups. CONCLUSION: Premedication with pregabalin (150 mg) reduces intraoperative sedative and perioperative analgesic requirement in patients undergoing ENT surgeries under monitored anesthesia care with tolerable side effects.
format Online
Article
Text
id pubmed-5490097
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-54900972017-06-29 Pregabalin in Monitored Anesthesia Care for Ear-nose-throat Surgery Kochhar, Anjali Banday, Jahanara Ahmad, Zainab Monga, Seema Vajifdar, Homay Anesth Essays Res Original Article AIM: The aim of this study was to determine intraoperative sedative and perioperative analgesic requirement and associated side effects of pregabalin (150 mg) for monitored anesthesia care during ear-nose-throat (ENT) surgeries. MATERIALS AND METHODS: The study design was randomized and single-blinded; fifty patients undergoing elective ambulatory ENT surgeries under monitored anesthesia care were randomly allocated to receive either placebo (Group P) or pregabalin (Group PG) 150 mg, orally 1 h before surgery. All patients were then given intravenous (i.v.) midazolam 2 mg and fentanyl 1 μg/kg and local anesthesia at the site. Sedation was induced by administering an i.v. bolus of propofol 0.8 mg/kg and was maintained by continuous infusion of propofol. Level of sedation was assessed by Ramsay scale, and propofol infusion was titrated accordingly. Intraoperative pain was assessed by verbal rating scale (VRS) score. Patient having VRS >4 or complaint of pain was given fentanyl (0.5 μg/kg) i.v. bolus. Intraoperative sedative and analgesic requirement were recorded. Postoperative visual analog scale scores and requirement of analgesics were recorded for the first 24 h after surgery. Diclofenac 75 mg intramuscular (i.m.) was administered as rescue analgesic. Side effects (nausea/vomiting, sedation, dizziness, blurred vision) were also recorded. RESULTS: Intraoperative propofol (212 ± 11 mg vs. 174 ± 9 mg; P = 0.013) and fentanyl (120 ± 8 μg vs. 94 ± 6 μg; P = 0.02) consumption was significantly lower in Group PG. Time to first analgesic request was longer (6.1 ± 0.4 h vs. 9.5 ± 1.2 h) with lesser requirement of analgesics (diclofenac) in the postoperative period. Incidence of side effects (sedation, nausea, vomiting) was found to be similar in both the groups. CONCLUSION: Premedication with pregabalin (150 mg) reduces intraoperative sedative and perioperative analgesic requirement in patients undergoing ENT surgeries under monitored anesthesia care with tolerable side effects. Medknow Publications & Media Pvt Ltd 2017 /pmc/articles/PMC5490097/ /pubmed/28663620 http://dx.doi.org/10.4103/0259-1162.194589 Text en Copyright: © 2016 Anesthesia: Essays and Researches http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Original Article
Kochhar, Anjali
Banday, Jahanara
Ahmad, Zainab
Monga, Seema
Vajifdar, Homay
Pregabalin in Monitored Anesthesia Care for Ear-nose-throat Surgery
title Pregabalin in Monitored Anesthesia Care for Ear-nose-throat Surgery
title_full Pregabalin in Monitored Anesthesia Care for Ear-nose-throat Surgery
title_fullStr Pregabalin in Monitored Anesthesia Care for Ear-nose-throat Surgery
title_full_unstemmed Pregabalin in Monitored Anesthesia Care for Ear-nose-throat Surgery
title_short Pregabalin in Monitored Anesthesia Care for Ear-nose-throat Surgery
title_sort pregabalin in monitored anesthesia care for ear-nose-throat surgery
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5490097/
https://www.ncbi.nlm.nih.gov/pubmed/28663620
http://dx.doi.org/10.4103/0259-1162.194589
work_keys_str_mv AT kochharanjali pregabalininmonitoredanesthesiacareforearnosethroatsurgery
AT bandayjahanara pregabalininmonitoredanesthesiacareforearnosethroatsurgery
AT ahmadzainab pregabalininmonitoredanesthesiacareforearnosethroatsurgery
AT mongaseema pregabalininmonitoredanesthesiacareforearnosethroatsurgery
AT vajifdarhomay pregabalininmonitoredanesthesiacareforearnosethroatsurgery